GAI
General American Investors Portfolio holdings
AUM $1.49B
1-Year Return
23.66%
This Quarter Return
+10.78%
1 Year Return
+23.66%
3 Year Return
+106.94%
5 Year Return
+191.29%
10 Year Return
+399.09%
AUM
$1.35B
AUM Growth
+$138M
(+11%)
Cap. Flow
+$13.6M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
48.67%
Holding
75
New
8
Increased
9
Reduced
16
Closed
4
Top Buys
| 1 |
Humana
HUM
|
+$12.8M |
| 2 |
Dominion Energy
D
|
+$12.8M |
| 3 |
Exxon Mobil
XOM
|
+$10.8M |
| 4 |
Valaris
VAL
|
+$10.2M |
| 5 |
Stevanato
STVN
|
+$9.63M |
Top Sells
| 1 |
HES
Hess
HES
|
+$12M |
| 2 |
Republic Services
RSG
|
+$9.57M |
| 3 |
Cigna
CI
|
+$8.17M |
| 4 |
Arch Capital
ACGL
|
+$6.93M |
| 5 |
Bath & Body Works
BBWI
|
+$6.02M |
Sector Composition
| 1 | Technology | 23.95% |
| 2 | Financials | 20.13% |
| 3 | Healthcare | 11.74% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tyler Technologies
TYL
$23.1B
| $15.5M | 1.11% |
36,381
| – | – |
|
27
Adobe
ADBE
$150B
| $15.1M | 1.08% |
30,000
+5,000
| +20% | +$2.52M |
|
28
Regeneron Pharmaceuticals
REGN
$60.9B
| $14M | 1% |
14,576
-2,000
| -12% | -$1.92M |
|
29
Alamos Gold
AGI
$13.3B
| $13.8M | 0.98% |
932,438
| – | – |
|
30
Chevron
CVX
$321B
| $12.9M | 0.92% |
81,991
| – | – |
|
|
31
Humana
HUM
$32.8B
| $12.8M | 0.92% |
+37,000
| New | +$12.8M |
|
|
32
Dominion Energy
D
$50.7B
| $12.8M | 0.91% |
+260,000
| New | +$12.8M |
|
33
Applied Materials
AMAT
$138B
| $12.7M | 0.91% |
61,652
| – | – |
|
34
Eaton
ETN
$145B
| $12.7M | 0.91% |
40,500
| – | – |
|
35
Danaher
DHR
$136B
| $12.5M | 0.89% |
50,010
| – | – |
|
36
Tenet Healthcare
THC
$16.2B
| $11.6M | 0.83% |
110,000
| – | – |
|
37
NextNav
NN
$2.27B
| $11M | 0.78% |
1,666,915
| – | – |
|
38
Universal Display
OLED
$6.51B
| $11M | 0.78% |
65,009
| – | – |
|
|
39
Exxon Mobil
XOM
$489B
| $10.8M | 0.77% |
+93,100
| New | +$10.8M |
|
40
Meta Platforms (Facebook)
META
$1.96T
| $10.7M | 0.76% |
22,000
| – | – |
|
|
41
Valaris
VAL
$3.77B
| $10.2M | 0.73% |
+136,106
| New | +$10.2M |
|
42
Pfizer
PFE
$136B
| $10.2M | 0.73% |
365,808
| – | – |
|
43
AXIS Capital
AXS
$7.38B
| $9.99M | 0.71% |
153,624
-50,000
| -25% | -$3.25M |
|
|
44
Stevanato
STVN
$7.43B
| $9.63M | 0.69% |
+300,000
| New | +$9.63M |
|
45
Medtronic
MDT
$121B
| $9.36M | 0.67% |
107,403
+2,403
| +2% | +$209K |
|
46
Gilead Sciences
GILD
$138B
| $8.78M | 0.63% |
119,900
| – | – |
|
47
T-Mobile US
TMUS
$267B
| $8.16M | 0.58% |
50,000
-7,848
| -14% | -$1.28M |
|
|
48
Cigna
CI
$78.5B
| $7.26M | 0.52% |
20,000
-22,500
| -53% | -$8.17M |
|
49
Amgen
AMGN
$147B
| $7.11M | 0.51% |
+25,000
| New | +$7.11M |
|
50
Algoma Steel
ASTL
$493M
| $6.93M | 0.5% |
816,056
| – | – |
|